Spanish Experts Unite Behind a Single Definition of Frailty to Guide Clinical Care and Research

Why this matters: Longer life expectancy has created health systems geared to acute, single diseases rather than the multidimensional needs of older adults. Frailty has become a central concept for preventing functional decline. Yet its use in routine practice, especially outside geriatrics, is held back by the lack of a universal definition, a gold-standard assessment tool, and enough evidence-based interventions. PubMed titles containing 'frailty' rose from 42 in 2004 to 2,664 in 2024, which makes conceptual clarity more urgent. Two competing frameworks have coexisted for two decades. Fried's phenotypic model describes heightened vulnerability to minor stressors. The Rockwood-Mitnitski model counts the accumulated burden of symptoms, signs, diseases, and disabilities. The authors note that these frameworks describe distinct constructs under one label.

What was done: The Spanish Research Consortium on Frailty and Healthy Aging (CIBERFES), funded by the Instituto de Salud Carlos III, produced a consensus position statement. It draws on 25 groups: eleven clinical, nine basic science, two in physical activity and exercise, and one each in nursing, nutrition, and health economics. The document aims to cover definition, attributes, misunderstandings, pathophysiology, phenotypes, assessment, biomarkers, management, stigma, gender considerations, and future challenges.

Key positions in the available text: Frailty is defined as an age-associated clinical phenotypic syndrome driven by aging biology, life-course environmental exposures, and disease burden. Its basis is a heterogeneous decline of functional reserve across organ systems, with impaired homeostasis and reduced stress response, which predisposes mainly to disability. This definition was previously agreed by Delphi expert consensus. The authors list five characteristics. First, frailty precedes disability and is its main risk factor, so it is a pre-disability state. Second, it sits on a functional continuum from robustness and intrinsic capacity to maximal dependence. Third, it is progressive, with a preclinical phase (pre-frailty) reported in up to 50% of community-dwelling older adults. There is no consensus on how to define pre-frailty, its cut-offs, or its prognostic meaning. Fourth, its causes are multifactorial: diseases, other geriatric syndromes, lifestyle, genetics, drugs, mental and psychosocial factors, and economic factors can trigger, accelerate, protect against, or modulate it, and may give rise to distinct sub-phenotypes (for example, predominant weakness, slow mobility, weight loss, or fatigue). Fifth, onset and progression can be prevented, delayed, slowed, or reversed. Treating frailty is described as a main strategy for avoiding disability, but reversibility falls sharply once dependency is severe. The authors also state that frailty cannot be separated from aging, so assessing it in people under about 50 may be of limited value.

Implications and caveats: The document gives clinicians, researchers, and policymakers a shared vocabulary and positions frailty as a modifiable target for preserving independence. It is an expert consensus, not a systematic review or trial. Pre-frailty definitions, a gold-standard tool, and sub-phenotype validation remain unresolved. The text available for this summary ends early in the document, so the detailed recommendations on assessment, biomarkers, management, stigma, gender, and the future roadmap could not be reviewed here.